Negative Pressure Wound Therapy Market Highlights:
The negative pressure wound therapy market share was volumed at USD 2.5 billion in 2022 and is
expected to rise from USD 2.6 Billion in 2023 to USD 4.16 billion by 2032,
exhibiting a compound annual growth rate (CAGR) of 6.1% during the forecast
period (2023 - 2032). The report profiles the global negative pressure wound
therapy market’s historical statistics to provide reliable insights and
predictions into the global negative pressure wound therapy market’s likely
growth trajectory over the forecast period. Key players and leading segments in
the global negative pressure wound therapy market are also profiled in the
report to provide readers with an accurate picture of the market’s inner
dynamics.
Negative
pressure wound therapy is carried out by covering a wound in a special sealed
dressing and exposing it to a vacuum, which draws out pus and other such
residue and helps clarify the wound by improving blood circulation in the
region. The global negative pressure wound therapy market has mainly grown in the 1990s and 2000s following the development of the
method and gradual growth in the awareness about its effectiveness. The growing
demand for wound healing systems that promote quick wound healing is expected
to be a major driver for the global negative pressure wound therapy market over
the forecast period. The clean and non-invasive nature of negative pressure
wound therapy is also likely to be a major market driver over the forecast
period.
The growing expenditure on wound care is likely to
be a key driver for the global negative pressure wound therapy market over the
forecast period. Factors such as the growing prevalence of diabetes could also
play a crucial role in the global negative pressure wound therapy market over
the forecast period, as the therapy is extensively used in the treatment of
diabetic ulcers.
Negative Pressure Wound Therapy Market Players
The global negative pressure wound therapy market players include
Acelity L.P. Inc.,
ConvaTec Group
plc,
Smith &
Nephew,
Talley Group,
Genadyne,
Molnlycke
Health Care AB,
Medela, Lohmann
& Rauscher International GmbH & Co. KG,
DeRoyal
Industries Inc., and
Cardinal
Health.
Segmentation:
The
global negative pressure wound therapy market outlook has been segmented on the basis of product type,
wound type, end user, and region.
On
the basis of product type, the negative pressure wound therapy market has been
segmented into conventional negative pressure wound therapy devices, single-use
negative pressure wound therapy devices, and accessories. The conventional
segment accounted for the largest share of the global market in 2017 due to its
effectiveness in handling large volumes of exudates.
By
wound type, the global negative pressure wound therapy market is segmented into
surgical and traumatic wounds, ulcers, and burns. The ulcers segment has been
further subclassified as venous ulcers, foot ulcers, pressure ulcers, and
others.
By
end use, the global negative pressure wound therapy market is segmented into
hospitals, home care settings, and others. Hospitals are likely to remain the
leading end user in the global negative pressure wound therapy market over the
forecast period due to their prominent role in wound care and
the easy availability of advanced negative pressure wound therapy systems in
hospitals.
Regional Analysis:
The
global negative pressure wound therapy market is segmented into the Americas,
Europe, the Middle East and Africa, and Asia Pacific. The Americas segment is
expected to dominate the global negative pressure wound therapy market over the
forecast period due to the growing demand for wound therapy in the region and
the increasing advancement of the healthcare sector, which is facilitating easy
access to advanced solutions such as negative pressure wound therapy across the
region. According to the National Diabetes Statistics Report, the U.S. housed
more than 30.3 million diabetics in 2017. This is likely to be a key driver for
the negative pressure wound therapy market in the region over the forecast
period.
Europe
is also likely to retain a dominant share in the global negative pressure wound
therapy market over the forecast period due to the technological advancement of
the healthcare sector in the region. Growing prevalence of diabetes could also
emerge as a key driver for the negative pressure wound therapy market in Europe
over the forecast period.
About US:
Market Research Future
(MRFR), enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th
Floor, New York,
New York 10013
United States of
America
